SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-006830
Filing Date
2023-04-26
Accepted
2023-04-26 16:10:41
Documents
18

Document Format Files

Seq Description Document Type Size
1 DEF 14A gbio-20230608xdef14a.htm   iXBRL DEF 14A 1336478
2 GRAPHIC gbio-20230608xdef14a_a003.jpg GRAPHIC 6777
3 GRAPHIC gbio-20230608xdef14a_a015.jpg GRAPHIC 46469
4 GRAPHIC gbio-20230608xdef14a_bg001.jpg GRAPHIC 126175
5 GRAPHIC gbio-20230608xdef14a_bg002.jpg GRAPHIC 119258
  Complete submission text file 0001558370-23-006830.txt   2777561

Data Files

Seq Description Document Type Size
6 EX-101.SCH gbio-20230608.xsd EX-101.SCH 6947
7 EX-101.DEF gbio-20230608_def.xml EX-101.DEF 6552
8 EX-101.LAB gbio-20230608_lab.xml EX-101.LAB 27118
9 EX-101.PRE gbio-20230608_pre.xml EX-101.PRE 12704
12 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20230608xdef14a_htm.xml XML 178354
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39319 | Film No.: 23849827
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences